The UK Advertising Standards Authority (ASA) has banned a Beauty Pie poster for its C-Wave Light Facial LED mask, ruling that the claim 'clinically proven to reduce wrinkles in 4 weeks' was misleading and lacked robust substantiation. The decision signals tighter scrutiny on LED mask marketing, a key category for aesthetic device distributors and clinic buyers.
Advert details and complaint
The poster, displayed on London Underground on 17 December 2025, featured an individual wearing the LED mask and stated: 'Skin tech that’s light years ahead […] C-Wave Facial LED treatment mask […] clinically proven to reduce wrinkles in 4 weeks.' Smaller text noted a 4-week study of 28 people aged 30-65. A complaint challenged whether the claim was misleading.
Beauty Pie's defense
Beauty Pie, a membership-based cosmetics company, argued the device was marketed solely for cosmetic purposes and not required to carry a UKCA medical device mark. It cited two product-specific clinical studies on the C-Wave mask and six peer-reviewed studies on equivalent technology. The company stated that participants used the mask three times per week for four weeks, with results showing a significant reduction in wrinkles.
ASA ruling and reasoning
The ASA concluded consumers would interpret 'clinically proven to reduce wrinkles in 4 weeks' as scientifically verified visible improvement, reinforced by the phrase 'skin tech that’s light years ahead.' The watchdog found the primary study had a small sample size of 28 participants with no statistical power analysis. It also noted that four supporting studies used a different device—panels positioned centimeters from the face—rather than a wearable mask, undermining comparability.
Regulatory and channel signals
The ASA ruled the advert breached CAP Codes on misleading advertising, substantiation, and health-related products. The ad must not appear again in its current form. Beauty Pie was told not to repeat the claim without adequate substantiation. This case underscores the need for device suppliers to ensure marketing claims are backed by product-specific, statistically robust clinical data, especially when targeting UK or EU markets.
What buyers should watch
For importers and clinic buyers sourcing LED masks, this ruling highlights the importance of verifying clinical evidence provided by manufacturers. Claims of 'clinically proven' should be supported by studies on the exact device model, with adequate sample sizes and statistical analysis. Distributors should request full study reports and check for regulatory compliance in target markets to avoid advertising bans and reputational risk.
Source: Read the original report | Published: June 11, 2026